Qiagen Nv Share Price (NYSE: QGEN)

$46.61

▲

-1.38

(-2.88%)

Live

Last updated on August 29, 2025 at 12:43 am IST

$₹

Check the interactive Qiagen Nv Stock chart to analyse performance

Qiagen Nv stock performance

as on August 29, 2025 at 12:43 am IST

Today's Low:$46.18
Today's High:$46.69
$46.61
0.92%
Downside
Day's Volatility :1.09%
Upside
0.17%
52 Weeks Low:$37.63
52 Weeks High:$51.88
$46.61
19.27%
Downside
52 Weeks Volatility :27.46%
Upside
10.15%

Qiagen Nv Stock Returns

Period	Qiagen Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	6.64%	4.2%	0.0%
6 Months	24.97%	-8.0%	0.0%
1 Year	1.85%	-12.1%	0.0%
3 Years	-1.19%	7.6%	-6.9%

Qiagen Nv Key Stats

Check Qiagen Nv key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$47.99
Open	$48.64
Today's High	$46.79
Today's Low	$45.86
Market Capitalization	$10.6B
Today's Volume	$796.2K
52 Week High	$51.875
52 Week Low	$37.63
Revenue TTM	$2.0B
EBITDA	$997.8M
Earnings Per Share (EPS)	$1.69
PE Ratio	28.91
Dividend Yield	0.51%
Profit Margin	18.3%
Quarterly Earnings Growth YOY	0.11%
Return On Equity TTM	10.81%

Stock Returns calculator for Qiagen Nv Stock including INR - Dollar returns

The Qiagen Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Qiagen Nv investment value today

Current value as on today

₹1,03,277

Returns

₹3,277

(+3.28%)

Returns from Qiagen Nv Stock

₹1,082 (-1.08%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Qiagen Nv Stock

-7%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Qiagen Nv Stock from India on INDmoney has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Qiagen Nv

Name
Holdings %
Name
Holdings %
Wellington Management Company LLP
12.00%
Massachusetts Financial Services Company
11.31%
Groupama Asset Management
7.38%
Vanguard Group Inc
4.27%
T. Rowe Price Associates, Inc.
2.74%
BlackRock Inc
2.52%

Analyst Recommendation on Qiagen Nv Stock

Rating

Trend

Buy

60%Buy

40%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Qiagen Nv(by analysts ranked 0 to 5 stars)

Qiagen Nv Share Price Target

What analysts predicted

Upside of 12.41%

Target:

$52.39

Current:

$46.61

Qiagen Nv share price target is $52.39, a slight Upside of 12.41% compared to current price of $46.61 as per analysts' prediction.

Qiagen Nv Stock Insights

Price Movement
In the last 7 days, QGEN stock has moved down by -2.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 483.45M → 533.54M (in $), with an average increase of 9.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 88.32M → 96.25M (in $), with an average increase of 4.2% per quarter
QGEN vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 33.1% return, outperforming this stock by 31.3%
QGEN vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 83.2% return, outperforming this stock by 85.4%
Price to Sales
ForQGEN every $1 of sales, investors are willing to pay $5.1, whereas for Idexx Laboratories, Inc., the investors are paying $12.9 for every $1 of sales.

Qiagen Nv Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.5B	↑ 1.64%
Net Income	$-41.5M	↓ 121.77%
Net Profit Margin	-2.72%	↓ 15.4%

	FY20	Y/Y Change
Revenue	$1.9B	↑ 22.53%
Net Income	$73.6M	↓ 277.64%
Net Profit Margin	3.94%	↑ 6.66%

	FY21	Y/Y Change
Revenue	$2.3B	↑ 20.39%
Net Income	$512.6M	↑ 596.09%
Net Profit Margin	22.77%	↑ 18.83%

	FY22	Y/Y Change
Revenue	$2.1B	↓ 4.89%
Net Income	$423.2M	↓ 17.44%
Net Profit Margin	19.76%	↓ 3.01%

	FY23	Y/Y Change
Revenue	$2.0B	↓ 8.23%
Net Income	$341.3M	↓ 19.35%
Net Profit Margin	17.37%	↓ 2.39%

	FY24	Y/Y Change
Revenue	$2.0B	↑ 0.66%
Net Income	$83.6M	↓ 75.51%
Net Profit Margin	4.23%	↓ 13.14%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$458.8M	↓ 9.89%
Net Income	$80.7M	↓ 17.4%
Net Profit Margin	17.58%	↓ 1.6%

	Q2 FY24	Q/Q Change
Revenue	$496.3M	↑ 8.18%
Net Income	$-183.5M	↓ 327.41%
Net Profit Margin	-36.96%	↓ 54.54%

	Q3 FY24	Q/Q Change
Revenue	$501.9M	↑ 1.11%
Net Income	$98.1M	↓ 153.45%
Net Profit Margin	19.54%	↑ 56.5%

	Q4 FY24	Q/Q Change
Revenue	$521.2M	↑ 3.85%
Net Income	$88.3M	↓ 9.93%
Net Profit Margin	16.95%	↓ 2.59%

	Q1 FY25	Q/Q Change
Revenue	$483.5M	↓ 7.24%
Net Income	$90.8M	↑ 2.76%
Net Profit Margin	18.77%	↑ 1.82%

	Q2 FY25	Q/Q Change
Revenue	$533.5M	↑ 10.36%
Net Income	$96.3M	↑ 6.05%
Net Profit Margin	18.04%	↓ 0.73%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.0B	↑ 0.43%

	FY20	Y/Y Change
Profit	$1.2B	↑ 22.14%

	FY21	Y/Y Change
Profit	$1.5B	↑ 18.16%

	FY22	Y/Y Change
Profit	$1.4B	↓ 4.57%

	FY23	Y/Y Change
Profit	$1.2B	↓ 10.9%

	FY24	Y/Y Change
Profit	$1.3B	↑ 7.38%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$291.0M	↓ 15.69%

	Q2 FY24	Q/Q Change
Profit	$34.8M	↓ 88.05%

	Q3 FY24	Q/Q Change
Profit	$308.3M	↑ 786.86%

	Q4 FY24	Q/Q Change
Profit	$349.8M	↑ 13.46%

	Q1 FY25	Q/Q Change
Profit	$308.7M	↓ 11.76%

	Q2 FY25	Q/Q Change
Profit	$334.3M	↑ 8.29%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$330.8M	↓ 7.97%
Investing Cash Flow	$-222.3M	↑ 5.17%
Financing Cash Flow	$-639.1M	↓ 277.32%

	FY20	Y/Y Change
Operating Cash Flow	$492.3M	↑ 48.79%
Investing Cash Flow	$-443.3M	↑ 99.43%
Financing Cash Flow	$-74.3M	↓ 88.37%

	FY21	Y/Y Change
Operating Cash Flow	$639.0M	↑ 29.81%
Investing Cash Flow	$-202.4M	↓ 54.33%
Financing Cash Flow	$-150.4M	↑ 102.32%

	FY22	Y/Y Change
Operating Cash Flow	$715.3M	↑ 11.93%
Investing Cash Flow	$-726.8M	↑ 259.03%
Financing Cash Flow	$-125.8M	↓ 16.34%

	FY23	Y/Y Change
Operating Cash Flow	$459.5M	↓ 35.76%
Investing Cash Flow	$-87.7M	↓ 87.94%
Financing Cash Flow	$-433.8M	↑ 244.85%

	FY24	Y/Y Change
Operating Cash Flow	$673.6M	↑ 46.6%
Investing Cash Flow	$-249.2M	↑ 184.33%
Financing Cash Flow	$-422.9M	↓ 2.52%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$133.1M	↓ 12.08%
Investing Cash Flow	$6.4M	↓ 111.0%
Financing Cash Flow	$-292.1M	↑ 3828.03%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$166.6M	↑ 25.2%
Investing Cash Flow	$-17.8M	↓ 377.36%
Financing Cash Flow	$-127.4M	↓ 56.39%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$182.3M	↑ 9.44%
Investing Cash Flow	$-231.0M	↑ 1195.27%
Financing Cash Flow	$485.6M	↓ 481.18%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$191.5M	↑ 5.02%
Investing Cash Flow	$-6.8M	↓ 97.06%
Financing Cash Flow	$-489.0M	↓ 200.71%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$139.7M	↓ 27.03%
Investing Cash Flow	$120.1M	↓ 1869.8%
Financing Cash Flow	$-286.7M	↓ 41.37%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$161.4M	↑ 15.53%
Investing Cash Flow	$-42.0M	↓ 134.97%
Financing Cash Flow	$-28.0M	↓ 90.24%

Qiagen Nv Technicals Summary

Sell

Neutral

Buy

Qiagen Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Qiagen Nv Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Qiagen Nv	-6.03%	24.97%	1.85%	-1.19%	-11.19%
Agilent Technologies Inc.	-0.96%	-6.6%	-15.86%	-7.35%	18.19%
Idexx Laboratories, Inc.	11.83%	45.31%	33.1%	83.6%	63.88%
Thermo Fisher Scientific, Inc.	1.24%	-6.71%	-20.39%	-12.32%	13.79%
Danaher Corp.	-0.89%	-0.35%	-22.95%	-25.91%	-0.71%
Iqvia Holdings Inc.	-2.96%	1.23%	-23.73%	-13.48%	15.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Qiagen Nv	28.91	28.91	1.11	2.35	0.11	0.09	0.01	16.17
Agilent Technologies Inc.	29.23	29.23	1.74	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	53.52	53.52	4.8	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.28	28.28	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.88	43.88	2.07	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.4	27.4	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Qiagen Nv	Buy	$10.6B	-11.19%	28.91	18.3%
Agilent Technologies Inc.	Buy	$33.7B	18.19%	29.23	17.59%
Idexx Laboratories, Inc.	Buy	$51.3B	63.88%	53.52	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.5B	13.79%	28.28	15.24%
Danaher Corp.	Buy	$147.7B	-0.71%	43.88	14.21%
Iqvia Holdings Inc.	Buy	$32.1B	15.3%	27.4	7.88%

Qiagen Nv Dividend announcements

Qiagen Nv Dividends September, 2025
In the quarter ending September,2025. Qiagen Nv has declared dividend of $0.25

About Qiagen Nv

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Organization	Qiagen Nv
Employees	5700
CEO	Mr. Thierry Bernard
Industry	Health Technology

Key Management of Qiagen Nv

Name	Title
Mr. Thierry Bernard	CEO, MD & Member of Management Board
Dr. Roland Sackers	CFO, MD & Member of Management Board
Mr. Antonio Santos	Senior VP & Head of Global Operations
Mr. John Gilardi	VP & Head of Corporate Communications
Dr. Dominic John	Vice President of Marketing & Product Management
Ms. Stephany Foster	Senior VP & Head of Human Resources
Dr. Thomas Schweins	Senior Vice President of Life Science Business Area
Dr. Thomas Theuringer	Senior Director & Head of External Communications
Mr. Jean-Pascal Viola	Senior VP & Head of Corporate Strategy and Business Development
Dr. Jonathan G. Sheldon Ph.D.	Senior VP & Head of the QIAGEN Digital Insights Business Area

Important FAQs about investing in QGEN Stock from India :

What is Qiagen Nv share price today?

Qiagen Nv share price today is $46.61 as on August 29, 2025 at 12:43 am IST. Qiagen Nv share today touched a day high of $46.69 and a low of $46.18.

What is the 52 week high and 52 week low for Qiagen Nv share?

Qiagen Nv share touched a 52 week high of $51.88 and a 52 week low of $37.63. Qiagen Nv stock price today i.e. August 29, 2025 at 12:43 am IST is trending at $46.61, lower by 10.15% versus the 52 week high.

How to invest in Qiagen Nv Stock (QGEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Qiagen Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Qiagen Nv Shares that will get you 0.0322 shares as per Qiagen Nv share price of $46.61 per share as on August 29, 2025 at 12:43 am IST.

What is the minimum amount required to buy Qiagen Nv Stock (QGEN) from India?

Indian investors can start investing in Qiagen Nv (QGEN) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Qiagen Nv stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Qiagen Nv share’s latest price of $46.61 as on August 29, 2025 at 12:43 am IST, you will get 0.2145 shares of Qiagen Nv. Learn more about fractional shares .

What are the returns that Qiagen Nv has given to Indian investors in the last 5 years?

Qiagen Nv stock has given -11.19% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?